Linxens of Levallois Perret at MEDICA 2022 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Company news

Date

Topic

24 Aug 2022

Linxens electrodes: A cost-effective & high-quality alternative to standard gold electrodes

The Point-of-Care market is facing an increased need for mass volume solutions to generalize patient monitoring. Thanks to its reel-to-reel manufacturing and know-how capabilities, Linxens is able to design and manufacture high volumes solutions and to develop advanced transceiver electrochemical strip solutions. The Linxens electrodes’ response signal is stable and well-defined and demonstrates a great reversibility and stability over cycling in the presence of Ferrocene Methanol. In blanks, a stable signal is obtained between -0,3 to + 0,3 V vs Ag/AgCl in PBS, and between -0.3V to 1.5V vs Ag/AgCl in PB.

Authors:
Youssef Ben M'Barek, Innovation Engineer
Simon Vassal, Innovation Manager

More Less

25 Jul 2022

Linxens technologies used to manufacture hundreds of millions of epoc® Test Cards

In critical care - intensive care units, emergency departments, operating rooms or neonatology units - fast turnaround time for diagnostic test results have been correlated to improved patient outcomes. The ability to rapidly analyze a range of basic biomarkers in patient blood can be vital.

Siemens Healthineers’ FDA and Health Canada approved epoc® Blood Analysis System, a so-called BGEM analyzer, was designed to specifically address these critical requirements.
It enables fast comprehensive analysis of blood gases (ie, pH, pCO2, pO2), electrolytes (ie, Na+, K+, Ca2+, Cl-), metabolites (ie, Glucose, Lactate, Urea, Creatinine)
and Haematocrit. It is a patient-side testing solution that delivers a full menu of laboratory-accurate tests in less than a minute.

More Less

Please log in

You must be logged in to use matchmaking